BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20193641)

  • 1. The role of p53 in apoptosis.
    Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
    Discov Med; 2010 Feb; 9(45):145-52. PubMed ID: 20193641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis.
    Amaral JD; Castro RE; Steer CJ; Rodrigues CM
    Trends Mol Med; 2009 Nov; 15(11):531-41. PubMed ID: 19822456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes.
    Solá S; Castro RE; Kren BT; Steer CJ; Rodrigues CM
    Biochemistry; 2004 Jul; 43(26):8429-38. PubMed ID: 15222754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the p53 pathway of apoptosis.
    Amaral JD; Xavier JM; Steer CJ; Rodrigues CM
    Curr Pharm Des; 2010; 16(22):2493-503. PubMed ID: 20500145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation.
    Park IH; Kim MK; Kim SU
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1025-30. PubMed ID: 18558085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death.
    Chari NS; Pinaire NL; Thorpe L; Medeiros LJ; Routbort MJ; McDonnell TJ
    Apoptosis; 2009 Apr; 14(4):336-47. PubMed ID: 19229632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes.
    Castro RE; Amaral JD; Solá S; Kren BT; Steer CJ; Rodrigues CM
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G327-34. PubMed ID: 17431217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual role of mutant p53 protein in chemosensitivity of human cancers.
    Mueller H; Eppenberger U
    Anticancer Res; 1996; 16(6B):3845-8. PubMed ID: 9042268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of the p53 pathway, apoptosis and cancer therapy.
    Vazquez A; Bond EE; Levine AJ; Bond GL
    Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease.
    Ramalho RM; Viana RJ; Low WC; Steer CJ; Rodrigues CM
    Trends Mol Med; 2008 Feb; 14(2):54-62. PubMed ID: 18218342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
    Newton HB
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells.
    Pani G; Bedogni B; Anzevino R; Colavitti R; Palazzotti B; Borrello S; Galeotti T
    Cancer Res; 2000 Aug; 60(16):4654-60. PubMed ID: 10969820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To die or not to die: how does p53 decide?
    Slee EA; O'Connor DJ; Lu X
    Oncogene; 2004 Apr; 23(16):2809-18. PubMed ID: 15077144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 tumor-suppressor gene: clues to molecular carcinogenesis.
    Wang XW; Harris CC
    J Cell Physiol; 1997 Nov; 173(2):247-55. PubMed ID: 9365531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL; Ling YF; Lai MD
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.